Guoxin health: to acquire equity of Yiyong technology and increase capital
Guoxin Health announced that the company plans to purchase 5.05% equity of Yiyong technology held by Shengshi Luowei in cash at a transaction price of 24.6 million yuan. After the completion of the above transfer, Guoxin health plans to invest 57.4 million yuan in cash to increase the capital of the target company. After the completion of the capital increase, the shareholding ratio of Guoxin health to the target company will reach 10.02%. Yiyong technology is a technology enterprise that carries out business around the tumor big data ecosystem.
This text is a result of machine translation.
Related companies：
Briefing Jan 20, 2022 10:49 PM
· Automotive
U.S. stocks of new energy vehicles generally rose, and Weilai automobile rose nearly 5%
Briefing Jan 19, 2022 08:59 PM
· Consumer Staples
Popular Chinese stocks fluctuated before the U.S. stock market, and individual stocks such as pinduoduo and Baidu rose more than 1%
In depth
Briefing Jan 18, 2022 08:39 PM
· Industrials
Ministry of Communications: we should do a good job in epidemic prevention and control and do a good job in energy and material transportation
Briefing Jan 18, 2022 12:59 PM
· Automotive
Xiaopeng automobile: 813 brand overcharging stations have been launched in China, and 166 destination charging stations have been established
Dec 28, 2021 06:19 PM
Aug 25, 2021 11:36 AM
Research
Automotive, TechnologyGlobal Auto Chip Shortage: Challenges, Opportunities and Implications for OEMs
Aug 04, 2021 03:41 PM
Jun 29, 2021 11:48 PM
Insight
Ride Federation: in December, BYD's wholesale sales of new energy were 93338 and Tesla China's 70847
See more
Read next
In depth
In depth
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.